GLP-1-RA such as liraglutide [4], semaglutide [5], and the dual agonist tirzepatide [6], activating both the GLP1- and the gastric-inhibitory polypeptide receptor (GIP-R), have been shown to significantly reduce body weight, making them a promising therapeutic option for the treatment of obesity
Glutathione exists in two forms: reduced (GSH, the active form) and oxidized (GSSG, the inactive form)
Yes, BPC-157 works when taken orally, particularly in gastrointestinal contexts, but clear evidence of effectiveness in humans remains limited
The medication's primary gastrointestinal side effectsparticularly nausea, vomiting, and diarrheacan lead to dehydration if fluid intake is inadequate or losses are not appropriately replaced
El producto no se recomienda para nios, mujeres embarazadas o en perodo de lactancia debido a la falta de datos suficientes